BMS Q2 net sales up
Net earnings attributable to BMS were $902m, compared to $927m for the same period in the prior year. For the six months ended 30 June 2011 net sales

Net earnings attributable to BMS were $902m, compared to $927m for the same period in the prior year. For the six months ended 30 June 2011 net sales

Zytiga is indicated with prednisone for the treatment of men with metastatic prostate cancer (castration-resistant prostate cancer) who have received prior chemotherapy containing docetaxel. The results from a

The companies have recruited around 549 patients in the trial. It enrolled 549 patients with mid- to late-stage idiopathic Parkinson’s disease (more than three years of disease duration)

The trial which will be conducted by ORA, an ophthalmic contract research organization, will start patient enrollment in next month. In the trial, the patients will be given

As per the terms of the contract, Sanofi is responsible to pay initial, approval and sales milestones to SkyePharma including single digit percentage on net sales. The tie

Michigan Eye Institute is an integrated eye-care practice with facilities in five locations in the Flint area of Michigan, US. Michigan Eye Institute MD Jeffrey Diskin said the

The trial results suggested that the drug was well tolerated at all dose levels and showed reduction in serotonin synthesis compared to placebo. The data from the study

The CRL was issued by the FDA in October 2010 for the NDA of the experimental type 2 diabetes drug Bydureon. In their reply, the companies have provided

Seasonique is a combination of female hormones that helps in preventing ovulation. Seasonique makes changes in the cervical mucus and uterine lining, to make it harder for sperm

FI6 is a neutralizing antibody which binds and neutralizes both Group 1 and Group 2 human and animal influenza A viruses. The researchers were able to culture single